Mary Anne Murphy
Optometrist · Broomfield, CONPI 1942272588
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (36.4%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Carl Zeiss Meditec, Inc. at 50.7% of the total. Reporting peaked in 2021 at $3,816 and has fallen 82.7% since, to $659 in 2025. Among optometrist clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 135 payments — averaging $98.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$7K
- Johnson & Johnson Vision Care, Inc.$2K
- Tarsus Pharmaceuticals, Inc.$1K
- Carl Zeiss Meditec USA, Inc.$1K
- Alcon$395
- Coopervision Inc.$375
- plus $2K from 14 others
What the payments were for
- Consulting fees$3,78029%
- Speaking & faculty fees$4,62035%
- Food & beverage$4,82236%
- Gifts$390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 15 | $6,717 |
| Johnson & Johnson Vision Care, Inc. | 10 | $1,665 |
| Tarsus Pharmaceuticals, Inc. | 5 | $1,304 |
| Carl Zeiss Meditec USA, Inc. | 23 | $1,187 |
| Alcon | 13 | $395 |
| Coopervision Inc. | 9 | $375 |
| AbbVie(2 entities) | 8 | $348 |
| Bausch & Lomb Americas Inc. | 10 | $254 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $202 |
| Sun Pharmaceutical Industries Inc. | 5 | $161 |
| Oyster Point Pharma, Inc. | 4 | $143 |
| Novartis | 7 | $125 |
| Harrow Eye, LLC | 2 | $80 |
| Kala Pharmaceuticals, Inc. | 4 | $72 |
| Glaukos Corporation | 1 | $50 |
| Shire North American Group Inc | 2 | $45 |
| Dompe US, Inc. | 2 | $42 |
| Carl Zeiss Meditec AG | 2 | $39 |
| ABB Con-cise Optical Group LLC | 5 | $34 |
| Visioneering Technologies, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FORUM$5,940
- CLARUS 500$3,520
- Humphrey HFA$3,520
- Glaucoma Workplace$2,200
- CIRRUS HD-OCT$2,094
- CIRRUS 5000$1,980
- Acuvue$1,455
- CLARUS$1,320
- XDEMVY$1,217
- CLARUS 500 Fundus Camera$303
- Precision7$144
- VUITY$117
- BIOTRUE ONE DAY$107
- MIEBO$105
How this compares
$13,261 in reported general payments places this provider in the 95th percentile of 1,025 optometrist providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 22 | $28,511 |
| MieboPerfluorohexyloctane/Pf | 22 | $25,512 |
| Timolol Maleate | 11 | $1,418 |
| Brimonidine Tartrate | 11 | $667 |
| Latanoprost | 41 | $579 |
| Prednisolone Acetate | 14 | $475 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $348 | $28,51122 claims |
| Bausch & Lomb Americas Inc.Miebo | $254 | $25,51222 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,025 optometrist providers in Colorado.
Other optometrist in Broomfield
- Scott GundersonBroomfield$43K
- Cecelia KoettingAurora$458K
- Kaleb AbbottAurora$145K
- Joshua OlsonBoulder$80K
- Felicia PopowskiFt Carson$80K
- Lisa HamiltonLittleton$73K
- Kent GodfreyGreenwood Village$49K
- Jason OrtmanCastle Pines$45K
- Scot MorrisConifer$33K
- Betty ZhangDenver$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.